skip to Main Content

Marijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring

GW Pharmaceuticals PLC reported Tuesday afternoon that sales of its cannabis-derived epilepsy drug more than doubled from the previous quarter, sending shares spiking more than 11% higher in after-hours trading. GW Pharmaceuticals GWPH, +10.22%  reported second-quarter sales of $68.4 million for Epidiolex, which uses…

Read More
Back To Top
×Close search
Search